These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 18331737)

  • 21. Association of measures of central fat accumulation indices with body fat distribution and metabolic, hormonal, and inflammatory parameters in women with polycystic ovary syndrome.
    Ribeiro VB; Kogure GS; Lopes IP; Silva RC; Pedroso DCC; Ferriani RA; Furtado CLM; Reis RMD
    Arch Endocrinol Metab; 2019 Jul; 63(4):417-426. PubMed ID: 31365630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of meal frequency on glucose and insulin levels in women with polycystic ovary syndrome: a randomised trial.
    Papakonstantinou E; Kechribari I; Mitrou P; Trakakis E; Vassiliadi D; Georgousopoulou E; Zampelas A; Kontogianni MD; Dimitriadis G
    Eur J Clin Nutr; 2016 May; 70(5):588-94. PubMed ID: 26862008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Favourable metabolic effects of a eucaloric lower-carbohydrate diet in women with PCOS.
    Gower BA; Chandler-Laney PC; Ovalle F; Goree LL; Azziz R; Desmond RA; Granger WM; Goss AM; Bates GW
    Clin Endocrinol (Oxf); 2013 Oct; 79(4):550-7. PubMed ID: 23444983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome.
    Javed Z; Papageorgiou M; Deshmukh H; Kilpatrick ES; Mann V; Corless L; Abouda G; Rigby AS; Atkin SL; Sathyapalan T
    Nutrients; 2019 Jan; 11(1):. PubMed ID: 30658483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
    Li X; Lin JF
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Associations between blood cadmium and endocrine features related to PCOS-phenotypes in healthy women of reproductive age: a prospective cohort study.
    Kim K; Pollack AZ; Nobles CJ; Sjaarda LA; Zolton JR; Radoc JG; Schisterman EF; Mumford SL
    Environ Health; 2021 May; 20(1):64. PubMed ID: 34022900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Low-Fat and High-Fat Meals, with and without Dietary Fiber, on Postprandial Endothelial Function, Triglyceridemia, and Glycemia in Adolescents.
    Whisner CM; Angadi SS; Weltman NY; Weltman A; Rodriguez J; Patrie JT; Gaesser GA
    Nutrients; 2019 Nov; 11(11):. PubMed ID: 31684015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dietary intake, glucose metabolism and sex hormones in women with polycystic ovary syndrome (PCOS) compared with women with non-PCOS-related infertility.
    Tsai YH; Wang TW; Wei HJ; Hsu CY; Ho HJ; Chen WH; Young R; Liaw CM; Chao JC
    Br J Nutr; 2013 Jun; 109(12):2190-8. PubMed ID: 23046530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AMH in combination with SHBG for the diagnosis of polycystic ovary syndrome.
    Calzada M; López N; Noguera JA; Mendiola J; Hernández AI; Corbalán S; Sanchez M; Torres AM
    J Obstet Gynaecol; 2019 Nov; 39(8):1130-1136. PubMed ID: 31208261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metastin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome.
    Yilmaz SA; Kerimoglu OS; Pekin AT; Incesu F; Dogan NU; Celik C; Unlu A
    Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():56-60. PubMed ID: 25020276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Opposing effects of dehydroepiandrosterone sulfate and free testosterone on metabolic phenotype in women with polycystic ovary syndrome.
    Lerchbaum E; Schwetz V; Giuliani A; Pieber TR; Obermayer-Pietsch B
    Fertil Steril; 2012 Nov; 98(5):1318-25.e1. PubMed ID: 22835450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin, androgens, and obesity in women with and without polycystic ovary syndrome: a heterogeneous group of disorders.
    Acién P; Quereda F; Matallín P; Villarroya E; López-Fernández JA; Acién M; Mauri M; Alfayate R
    Fertil Steril; 1999 Jul; 72(1):32-40. PubMed ID: 10428145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterogenous origins of hyperandrogenism in the polycystic ovary syndrome in relation to body mass index and insulin resistance.
    Patlolla S; Vaikkakara S; Sachan A; Venkatanarasu A; Bachimanchi B; Bitla A; Settipalli S; Pathiputturu S; Sugali RN; Chiri S
    Gynecol Endocrinol; 2018 Mar; 34(3):238-242. PubMed ID: 29068242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of long-term orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndrome.
    Diamanti-Kandarakis E; Katsikis I; Piperi C; Alexandraki K; Panidis D
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):103-9. PubMed ID: 17201808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired cholecystokinin secretion and disturbed appetite regulation in women with polycystic ovary syndrome.
    Hirschberg AL; Naessén S; Stridsberg M; Byström B; Holtet J
    Gynecol Endocrinol; 2004 Aug; 19(2):79-87. PubMed ID: 15624269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of oral fat and glucose tolerance test on serum lipid profile, apolipoprotein, and CRP concentration, and insulin resistance in patients with polycystic ovary syndrome.
    Bahceci M; Aydemir M; Tuzcu A
    Fertil Steril; 2007 Jun; 87(6):1363-8. PubMed ID: 17362944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin resistance is not strictly associated with energy intake or dietary macronutrient composition in women with polycystic ovary syndrome.
    Toscani MK; Mario FM; Radavelli-Bagatini S; Spritzer PM
    Nutr Res; 2011 Feb; 31(2):97-103. PubMed ID: 21419313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessing beans as a source of intrinsic fiber on satiety in men and women with metabolic syndrome.
    Reverri EJ; Randolph JM; Kappagoda CT; Park E; Edirisinghe I; Burton-Freeman BM
    Appetite; 2017 Nov; 118():75-81. PubMed ID: 28735851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The association of serum androgens and insulin resistance with fat distribution in polycystic ovary syndrome.
    Yucel A; Noyan V; Sagsoz N
    Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):81-6. PubMed ID: 16337726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Obesity, hormonal and metabolic abnormalities in adolescent girls with polycystic ovary syndrome].
    Ságodi L; Lombay B; Vámosi I; Barkai L
    Orv Hetil; 2013 Aug; 154(31):1226-34. PubMed ID: 23895991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.